|
1
|
World Health Organization (WHO): Obesity
and overweight. WHO, Geneva, 2019. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
Accessed November 20, 2019.
|
|
2
|
Onalan R, Onalan G, Tonguc E, Ozdener T,
Dogan M and Mollamahmutoglu L: Body mass index is na independente
risk factor for the development of endometrial polyps in patients
unfergoing in vitro fertilization. Fertil Steril. 91:1056–1060.
2009.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Costa-Paiva I, Godoy CE Jr, Antunes A Jr,
Caseiro JD, Arthuso M and Pinto-Neto AM: Risk of malignancy in
endometrial polyps in premenopausal and postmenopausal women
according to clinicopathologic characteristics. Menopause.
18:1278–1282. 2011.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Dreisler E, Stampe SS, Ibsen PH and Lose
G: Prevalence of endometria polyps and abnormal uterine bleeding in
a Danish population aged 20-74 years. Ultrasound Obstet Gynecol.
33:102–108. 2009.PubMed/NCBI View
Article : Google Scholar
|
|
5
|
Pinheiro A, Antunes Jr A, Andrade L, Brot
L, Pinto-Neto AM and Costa-Paiva L: Expression of hormone
receptors, BCL2, Cox-2 and MKI67 in benign endometrial polyps and
their association with obesity. Mol Med Rep. 9:2335–2341.
2014.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Taylor LJ, Jackson TL, Reid JG and Duffy
SRG: The differential expression of oestrogen receptors,
progesterone receptors, Bcl-2 and Ki67 in endometrial polyps. BJOG.
110:794–798. 2003.PubMed/NCBI
|
|
7
|
Amezcua CA, Zheng W, Muderspach LI and
Felix JC: Down-regulation of BCL2 is a potential marker of the
efficacy of progestin therapy in the treatment of endometrial
hyperplasia. Gynecol Oncol. 73:126–136. 1999.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Nogueira AA: Pólipos endometriais. Rev
Bras Ginecol Obstet. 27:289–292. 2005.
|
|
9
|
Vinatier D, Dufour P and Subtil D:
Apoptosis: A programmed cell death involved in ovarian and uterine
physiology. Eur J Obstet Gynecol Reprod Biol. 67:85–102.
1996.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Inceboz US, Nese N, Uyar Y, Ozcakir HT,
Kurtul O, Baytur YB, Kandiloglu AR, Caglar H and Fraser IS: Hormone
receptor expressions and proliferation markers in postmenopausal
endometrial polyps. Gynecol Obstet Invest. 61:24–28.
2006.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Arends MJ: Apoptosis in the endometrium.
Histopathology. 35:174–178. 1999.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Gompel A, Sabourin JC, Martin A, Yaneva H,
Audouin J, Decroix Y and Poitout P: BCL2 expression in normal
endometrium during the menstrual cycle. Am J Pathol. 144:1195–1202.
1994.PubMed/NCBI
|
|
13
|
Mittal K, Schwartz I, Goswami S and
Demopoulos R: Estrogen and progesterone receptors in the
endometrial polyps. Int J Gynecol Pathol. 15:345–348.
1996.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Gul A, Ugur M, Iskender C, Zulfikaroglu E
and Ozaksit G: Immunohistochemical expression of estrogen and
progesterone receptors in endometrial polyps and its relationship
to clinical parameters. Arch Gynecol Obstet. 281:479–483.
2010.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Belisario MSN, Vassallo J, Andrade LALA,
Alvarenga M, Pinto GA and Monteiro IMU: The expression of the
hormone receptors in the endometrium and endometrial polyps in
postmenopausal women and its relationship to body mass index.
Maturitas. 53:114–118. 2006.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Siiteri PK and Mac Donald PC: Role of
extraglandular estrogen in human endocrinology. In: Handbook of
Physiology. Geyer SR, Astwood EB and Greep RD (eds); Endocrinology,
American Physiology Society, Washington DC, pp615, 1973.
|
|
17
|
Oguz S, Sargin A, Kelekci S, Aytan H,
Tapisiz OL and Mollamahmutoglu L: The role of hormone replacement
therapy in endometrial polyps formation. Maturitas. 50:231–236.
2005.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Villavicencio A, Aguilar G, Argüello G,
Dünner C, Gabler F, Soto E, Gaete F, Peñaloza P, Celis M and Rojas
C: The effect of overweight and obesity on proliferation and
activation of AKT and ERK in human endometria. Gynecol Oncol.
117:96–102. 2010.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Stănescu AD, Nistor I, Potecã AG, Ditescu
D and Comãnescu M: Prognostic biomarkers in endometrial
adenocarcinoma. Rom J Morphol Embryol. 55:1339–1344.
2014.PubMed/NCBI
|
|
20
|
Troncon JK, Meola J, Candido-Dos-Reis FJ,
Poli-Neto OB, Nogueira AA and Rosa-E-Silva JC: Analysis of
differential genetic expression in endometrial polyps of
postmenopausal women. Climacteric. 20:462–466. 2017.PubMed/NCBI View Article : Google Scholar
|
